Literature DB >> 2116115

Small intestinal permeability and orocaecal transit time in cystic fibrosis.

A M Dalzell1, N S Freestone, D Billington, D P Heaf.   

Abstract

Cellobiose and mannitol were used as probe molecules to measure intestinal permeability in 36 children with cystic fibrosis, and 25 age matched controls. Orocaecal transit was also evaluated for each subject using the lactulose/hydrogen breath test. There was a fourfold increase in permeability to disaccharide (cellobiose) in patients with cystic fibrosis, but permeability to the monosaccharide (mannitol) was similar to controls. The orocaecal transit time of lactulose was prolonged in patients with cystic fibrosis, but was unrelated to the percentage excretion of cellobiose or mannitol in cystic fibrosis patients or control subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116115      PMCID: PMC1792075          DOI: 10.1136/adc.65.6.585

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

1.  LIGHT AND ELECTRON MICROSCOPIC EXAMINATION OF THE SMALL BOWEL OF CHILDREN WITH CYSTIC FIBROSIS.

Authors:  H B FREYE; S M KURTZ; A SPOCK; M P CAPP
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Disaccharides and cystic fibrosis of the pancreas.

Authors:  I S Gibbons
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

3.  Fetal abnormalities in cystic fibrosis suggest a deficiency in proteolysis of cholecystokinin.

Authors:  C M Gosden; J R Gosden
Journal:  Lancet       Date:  1984-09-08       Impact factor: 79.321

4.  Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge.

Authors:  I Hamilton; I Cobden; J Rothwell; A T Axon
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

Review 5.  Gastrointestinal manifestations of cystic fibrosis: a review.

Authors:  R W Park; R J Grand
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

6.  Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum.

Authors:  S Strobel; W G Brydon; A Ferguson
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

7.  Prolonged small-intestinal transit time in cystic fibrosis.

Authors:  A Bali; D E Stableforth; P Asquith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

8.  Mannitol estimation in biological fluids by gas-liquid chromatography of trimethylsilyl derivatives.

Authors:  M F Laker; J N Mount
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

9.  Cellobiose/mannitol test: physiological properties of probe molecules and influence of extraneous factors.

Authors:  I Cobden; I Hamilton; J Rothwell; A T Axon
Journal:  Clin Chim Acta       Date:  1985-05-15       Impact factor: 3.786

10.  Intestinal permeability and screening tests for coeliac disease.

Authors:  I Cobden; J Rothwell; A T Axon
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

View more
  18 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Small-intestinal abnormalities in cystic fibrosis patients.

Authors:  E Eggermont; K De Boeck
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

4.  Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease.

Authors:  K N Davies; D King; D Billington; J A Barrett
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

Review 5.  Subclinical colonic thickening.

Authors:  P J Oades; M Rosenthal; E J Mac Sweeney; A Bush
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

6.  Electrogastrography in children with cystic fibrosis.

Authors:  Atiye Nur Aktay; Mark L Splaingard; Tami Miller; Mary Ellen Freeman; Heidi Hoeppner; Steven L Werlin
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

7.  Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Racquel Mueller; Megan Boyd
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

8.  Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.

Authors:  Oxana Norkina; Tim G Burnett; Robert C De Lisle
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Orocaecal transit time in patients with Crohn disease.

Authors:  H Götze; A Ptok
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

10.  Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine.

Authors:  R C de Lisle; R Sewell; L Meldi
Journal:  Neurogastroenterol Motil       Date:  2009-10-08       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.